Kiniksa Pharmaceuticals GAAP EPS of -$0.29 beats by $0.15, revenue of $26.97M misses by $1.58M, reaffirms FY revenue guidance
Kiniksa Pharmaceuticals GAAP EPS of -$0.29 beats by $0.15, revenue of $26.97M misses by $1.58M, reaffirms FY revenue guidance
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
-
TDCX Non-GAAP EPS of $0.15 beats by $0.03, revenue of $116.6M beats by $2.12M, reaffirms FY guidance
SeekingAlpha
-
Illumina GAAP EPS of $0.57 beats by $0.21, revenue of $1.16B misses by $60M, cuts FY22 guidance
SeekingAlpha
-
Wolverine World Wide Non-GAAP EPS of $0.66 beats by $0.01, revenue of $713.6M misses by $25.1M, updates FY guidance
SeekingAlpha
-
Syros Pharmaceuticals GAAP EPS of -$0.54 misses by $0.13, revenue of $6.28M beats by $1.5M
SeekingAlpha
Advertisement
More coverage
-
Reata Pharmaceuticals Non-GAAP EPS of -$1.36 beats by $0.61, revenue of $0.76M misses by $0.7M
SeekingAlpha
-
Amneal Pharmaceuticals Non-GAAP EPS of $0.19 in-line, revenue of $559M beats by $24.56M, revises FY earning guidance
SeekingAlpha
-
WeWork GAAP EPS of -$0.76 misses by $0.20, revenue of $815M misses by $9.31M, reaffirms FY guidance
SeekingAlpha
-
Rhythm Pharmaceuticals GAAP EPS of -$0.89 beats by $0.06, revenue of $2.31M misses by $0.26M
SeekingAlpha